The patent EP3986887A1 was granted to Abbvie Biotechnology on Apr 27, 2022 following the initial filing on Jun 18, 2020 under the application number EP20737701A . The current legal status of the patent is Request For Examination Was Made.
The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.
Date
Description
Get instant alerts for new documents